World's Best Scientists 2026 revealed!
Monica M. Farley

Monica M. Farley

D-Index & Metrics

Microbiology

D-Index
106
Citations
52530
World Ranking
292
National Ranking
133

Medicine

D-Index
106
Citations
52959
World Ranking
6409
National Ranking
3415

Monica M. Farley publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Monica M. Farley sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 301 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Monica M. Farley D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Monica M. Farley sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 106 D-Index — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Monica M. Farley is affiliated with Emory University in the United States and has a research focus within the field of Medicine. Their work spans multiple subfields including Epidemiology, Infectious Diseases, Microbiology, Public Health, Environmental and Occupational Health, and Immunology.

The scientist has contributed to various topics primarily related to infectious diseases and respiratory conditions. The main areas of research include:

  • Pneumonia and Respiratory Infections
  • Bacterial Infections and Vaccines
  • Antifungal resistance and susceptibility
  • Respiratory viral infections research
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Streptococcal Infections and Treatments
  • Fungal Infections and Studies

Monica M. Farley's recent notable papers cover various infectious disease topics. These include:

  • "Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes," 2020, published in New England Journal of Medicine
  • "Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years - COVID-NET, 13 States, February-April 2021," 2021, published in MMWR Morbidity and Mortality Weekly Report
  • "Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study - United States, August 19, 2022-March 31, 2023," 2023, published in MMWR Morbidity and Mortality Weekly Report
  • "Burden of Candidemia in the United States, 2017," 2020, published in Clinical Infectious Diseases
  • "Use of Baricitinib in Patients With Moderate to Severe Coronavirus Disease 2019," 2020, published in Clinical Infectious Diseases

The scientist has collaborated frequently with several colleagues, with their most common coauthors being:

  • Lee H. Harrison
  • William Schaffner
  • Ann Thomas
  • Susan Petit
  • Ryan Gierke

Their research outputs are published predominantly in venues focused on infectious diseases and epidemiology. The most frequent publication venues include:

  • Open Forum Infectious Diseases
  • Clinical Infectious Diseases
  • The Journal of Infectious Diseases
  • Infection Control and Hospital Epidemiology
  • MMWR Morbidity and Mortality Weekly Report

Best Publications

  • Burden of Clostridium difficile Infection in the United States

    Fernanda C. Lessa;Yi Mu;Wendy M. Bamberg;Zintars G. Beldavs

  • Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

    Cynthia G. Whitney;Monica M. Farley;James Hadler;Lee H. Harrison

  • Methicillin-resistant Staphylococcus aureus disease in three communities.

    Scott K. Fridkin;Jeffrey C. Hageman;Melissa Morrison;Laurie Thomson Sanza

  • Bacterial Meningitis in the United States in 1995

    Anne Schuchat;Katherine Robinson;Jay D. Wenger;Lee H. Harrison

  • Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine

    Tamara Pilishvili;Catherine Lexau;Monica M. Farley;Monica M. Farley;James Hadler

  • Group B Streptococcal Disease in the Era of Intrapartum Antibiotic Prophylaxis

    Stephanie J. Schrag;Sara Zywicki;Monica M. Farley;Arthur L. Reingold

  • Bacterial Meningitis in the United States, 1998-2007

    Michael C Thigpen;Cynthia G Whitney;Nancy E Messonnier;Elizabeth R Zell

  • Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.

    Cynthia G. Whitney;Monica M. Farley;James Hadler;Lee H. Harrison

  • Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005.

    Christina R. Phares;Ruth Lynfield;Monica M. Farley;Janet Mohle-Boetani

  • Cigarette Smoking and Invasive Pneumococcal Disease

    J P Nuorti;J C Butler;M M Farley;L H Harrison

  • Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-Resistant Streptococcus pneumoniae

    Moe H. Kyaw;Ruth Lynfield;William Schaffner;Allen S. Craig

  • Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: Analysis of multisite, population-based surveillance

    Matthew R Moore;Ruth Link-Gelles;William Schaffner;Ruth Lynfield

  • FoodNet Estimate of the Burden of Illness Caused by Nontyphoidal Salmonella Infections in the United States

    Andrew C. Voetsch;Thomas J. Van Gilder;Frederick J. Angulo;Monica M. Farley

  • Incidence of Pneumococcal Disease Due to Non-Pneumococcal Conjugate Vaccine (PCV7) Serotypes in the United States during the Era of Widespread PCV7 Vaccination, 1998–2004

    Lauri A. Hicks;Lee H. Harrison;Brendan Flannery;James L. Hadler

  • Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine.

    Catherine A. Lexau;Ruth Lynfield;Richard Danila;Tamara Pilishvili

  • Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997.

    Daniel R. Feikin;Anne Schuchat;Margarette Kolczak;Nancy L. Barrett

  • Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes.

    Alice Y. Guh;Yi Mu;Lisa G. Winston;Helen Johnston

  • The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta.

    Jo Hofmann;Martin S. Cetron;Monica M. Farley;Wendy S. Baughman

  • Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study.

    Cynthia G. Whitney;Tamar Pilishvili;Monica M. Farley;William Schaffner

  • A Population-Based Assessment of Invasive Disease Due to Group B Streptococcus in Nonpregnant Adults

    M M Farley;R C Harvey;T Stull;J D Smith

  • Active bacterial core surveillance of the emerging infections program network.

    Schuchat A;Hilger T;Zell E;Farley Mm

Frequent Co-Authors

Lee H. Harrison
Lee H. Harrison University of Pittsburgh
Ruth Lynfield
Ruth Lynfield Minnesota Department of Health
William Schaffner
William Schaffner Vanderbilt University
Arthur L. Reingold
Arthur L. Reingold University of California, Berkeley
Nancy M. Bennett
Nancy M. Bennett University of Rochester Medical Center
Bernard Beall
Bernard Beall Centers for Disease Control and Prevention
Shelley M. Zansky
Shelley M. Zansky New York State Department of Health
Anne Schuchat
Anne Schuchat Centers for Disease Control and Prevention
Cynthia G. Whitney
Cynthia G. Whitney Emory University
David S. Stephens
David S. Stephens Emory University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career paths, many of which offer flexible online education options. For those interested in healthcare administration, a fast track medical billing and coding certificate online can provide a quick entry into the medical field with growing demand. This path complements scientific knowledge with essential administrative skills.

Medical degrees online are another option for microbiology graduates aiming to expand their expertise and pursue clinical roles. These programs often cater to working professionals seeking flexible schedules while advancing their qualifications.

For careers focused on public health, enrolling in an mph online programs with easy admission requirements can be a practical step. Microbiology students can leverage such degrees to work in epidemiology, health policy, or community health, influencing broader health outcomes.

Additionally, some microbiologists find fulfilling roles in child health and development. Insights into these roles, including salary expectations, can be explored through resources like child specialist salary, providing valuable information for those considering related specialties.

Best Scientists Citing Monica M. Farley

Trending Scientists

Recently Published Articles